Aa
Aa
A
A
A
Close
9624973 tn?1413016130

REPLICor Press release Dec 1, 2014

REPLICor a biopharmaceutical company targeting a cure for Chronic Hepatitis B patients will present updated human clinical trial data documenting a 4 to 6 log reduction in s-antigen and a long-term SVR in 80% of patients.

December 1, 2014 – Recently updated clinical trial data from REPLICor’s Phase 2 trials will be presented at the Piper Jaffray Healthcare Conference Dec 3rd in New York City. REPLICor’s Chief Scientific Officer Dr. Andrew Vaillant Ph.D. will participate in the panel discussion on approaches to treat HBV on Wednesday morning.

REPLICor’s nucleic acid polymer (NAP) HBsAg (s-antigen)-release inhibitors therapy blocks s-antigen release and can effectively eliminate s-antigen from the blood (as an example, the serum HBsAg in one patient was reduced from 87,690 to 0.01 IU / ml on treatment, a 6.94 log reduction). REPLICor has currently tested its NAP technology in three different human clinical trials in Asia using different treatment modalities: in monotherapy, in combination with short-term immunotherapy and in combination with a complete course of Pegasys™ with the latter regimen resulting in the maintenance of long-term SVR in 80% of patients for greater than 6 months after all treatment is withdrawn.

“Our data suggests that eliminating surface antigen will be a critical part of a multi-step process that will be necessary to achieve a high SVR. Eliminating surface antigen will require a multi-log reduction which our drug has been shown to accomplish in human clinical trials,” said Dr. Vaillant. “We look forward to further validation of NAP activity from additional clinical trials over the next 12 months.”

REPLICor is a privately held biopharmaceutical company. For further information about REPLICor please visit our website www.replicor.com. Inquires about the company can be directed to ***@****.

3 Responses
Sort by: Helpful Oldest Newest
Avatar universal
we have to see if it is sustained by immune system because hbsag is not removed by immune system but artificially just blocked the release by rep9ac
Helpful - 0
Avatar universal
Long term SVR of 80%...shouldn't it be construed as cure?
Helpful - 0
Avatar universal
Hopefully, in the following 3-4 years, Hep B will be no more dangerous than flue.
Helpful - 0
Have an Answer?

You are reading content posted in the Hepatitis B Community

Didn't find the answer you were looking for?
Ask a question
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.